Search Results - "Chaury, MP"

Early Treatment of Anemia of Lower Risk MDS by Erythropoiesis-Stimulating Agents (ESAs): A Report On 112 Cases by Park, Sophie, Kelaidi, C., Sapena, Rosa, Vassilieff, D., Beyne-Rauzy, Odile, Coiteux, Valerie, Vey, Norbert, Ravoet, Christophe, Cheze, Stéphane, Rose, Christian, Legros, Laurence, Stamatoullas, Aspasia, Escoffre-Barbe, Martine, Guerci, Agnes, Chaury, MP, Fenaux, Pierre, Dreyfus, Francois

“…Abstract 1765 Poster Board I-791 ESAs are frequently effective in anemia of lower risk MDS, and at least 2 groups have shown that ESAs did not increase the…”
Get full text

Interim Results of A Randomized Phase II Trial of Azacitidine (AZA) +/− Epo In Lower Risk Myelodysplastic Syndrome (MDS) Resistant to An Erythropoietic Stimulating Agent (ESA) Alone by Boehrer, Simone, Beyne-Rauzy, Odile, Prebet, Thomas, Park, Sophie, Guerci, Agnès, Stamatoulas, Aspasia, Chaury, MP, Jernival, Tony, Sanhes, Laurence, Tertian, Gerard, Cheze, Stephane, Lim, Eng-Mong, Choufi, Bachra, Caillot, Denis, Wattel, E., Delaunay, Jacques, Legros, Laurence, Chermat, Fatiha, Isnard, Françoise, Cambier, N., Slama, Borhane, Roy, Lydia, Damaj, Gandhi, Raffoux, Emmanuel, Dreyfus, Francois, Récher, Christian, Vey, Norbert, Chevret, Sylvie, Fenaux, Pierre, Gardin, Claude

“…Abstract 1880 Red blood cell (RBC) cell transfusion dependency (TD) is an indicator of poor prognosis in IPSS low and int-1 (lower risk) MDS. In addition,…”
Get full text

Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup by Petit, B, Chaury, MP, Le Clorennec, C, Jaccard, A, Gachard, N, Moalic-Judge, S, Labrousse, F, Cogne, M, Bordessoule, D, Feuillard, J

“…Laboratoire d'Anatomie Pathologique, France. BACKGROUND AND OBJECTIVES: Small B-cell indolent lymphomas postulated to be of a post-germinal center origin…”
Get full text

Azacytidine (AZA) as First Line Therapy in AML: Results of the French ATU Program by Thépot, Sylvain, Itzykson, Raphael, Seegers, Valerie, Recher, Christian, Quesnel, Bruno, Delaunay, Jacques, Cluzeau, Thomas, Koka, Anne Marfaing, Stamatoullas, Aspasia, Chaury, MP, Dartigeas, Caroline, Cheze, Stéphane, Salanoubat, Celia, Morel, Pierre, Plantier, Isabelle, Taksin, Anne-Laure, Marolleau, Jean Pierre, Pautas, Cecile, Wattel, Eric, Isnard, Francoise, Sanhes, Laurence, Harel, Stephanie, de Botton, Stephane, Chait, Yasmine, Uzunov, Madalina, Guerci, Agnes, Dahoun, Mehdi, Vey, Norbert, Dombret, Herve, Dreyfus, Francois, Ades, Lionel, Fenaux, Pierre, Gardin, Claude

“…Abstract 843 AZA prolongs survival in higher-risk MDS including patients (pts) with 20-29 % marrow blasts, now considered WHO-AML ( Lancet Onc, 2009). However,…”
Get full text

Myelodysplastic Syndrome (MDS) in France: Results of a One-Week Cross-Sectional Survey on Daily Practice Management in 919 Patients by the GFM by Kelaidi, C., Stamatoullas, Aspasia, Beyne-Rauzy, Odile, Dreyfus, Francois, Quesnel, Bruno, Guerci, Agnes, Raffoux, E., Brechignac, S., Vassilieff, D., Prebet, T., Hicheri, Yosr, Legros, Laurence, Chaury, MP, Zerazhi, H., Camo, J., Berthou, Christian, Hacini, M., Taksin, Anne-Laure, Delaunay, Jacques, Choufi, B., Lafon, Ingrid, Ame, S., Dine, G., Cheze, Stéphane, Ghomari, K., Fenaux, Pierre

“…Background: Epidemiological data on MDS is scarce in France, and registries from other countries do not provide data on the daily practice management of MDS in…”
Get full text